# A Study Evaluating the Safety and Efficacy of AVE5530 (4 Weeks) in Patients With Mild to Moderate Hypercholesterolemia

> **NCT00440154** · PHASE2 · COMPLETED · sponsor: **Sanofi** · enrollment: 206 (actual)

## Conditions studied

- Hypercholesterolemia

## Interventions

- **DRUG:** AVE5530
- **DRUG:** placebo
- **DRUG:** ezetimibe

## Key facts

- **NCT ID:** NCT00440154
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** 2007-10
- **Final completion:** 2007-10
- **Target enrollment:** 206 (ACTUAL)
- **Last updated:** 2008-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00440154

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00440154, "A Study Evaluating the Safety and Efficacy of AVE5530 (4 Weeks) in Patients With Mild to Moderate Hypercholesterolemia". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00440154. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*